BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 24830712)

  • 21. MicroRNA-based Biosensors for Early Detection of Cancers.
    Rezayi M; Farjami Z; Hosseini ZS; Ebrahimi N; Abouzari-Lotf E
    Curr Pharm Des; 2018; 24(39):4675-4680. PubMed ID: 30636591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis.
    Kosaka N; Iguchi H; Ochiya T
    Cancer Sci; 2010 Oct; 101(10):2087-92. PubMed ID: 20624164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating microRNAs as noninvasive biomarkers in breast cancer.
    Cortez MA; Welsh JW; Calin GA
    Recent Results Cancer Res; 2012; 195():151-61. PubMed ID: 22527502
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methylated DNA and microRNA in body fluids as biomarkers for cancer detection.
    Ma Y; Wang X; Jin H
    Int J Mol Sci; 2013 May; 14(5):10307-31. PubMed ID: 23681012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical relevance of circulating cell-free microRNAs in cancer.
    Schwarzenbach H; Nishida N; Calin GA; Pantel K
    Nat Rev Clin Oncol; 2014 Mar; 11(3):145-56. PubMed ID: 24492836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating microRNAs in hematological diseases: principles, challenges, and perspectives.
    Grasedieck S; Sorrentino A; Langer C; Buske C; Döhner H; Mertens D; Kuchenbauer F
    Blood; 2013 Jun; 121(25):4977-84. PubMed ID: 23550041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating microRNAs as Reliable Tumor Biomarkers: Opportunities and Challenges Facing Clinical Application.
    El-Daly SM; Gouhar SA; Abd Elmageed ZY
    J Pharmacol Exp Ther; 2023 Jan; 384(1):35-51. PubMed ID: 35809898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Circulating microRNAs in the diagnostics of endocrine neoplasms].
    Decmann Á; Perge P; Nagy Z; Butz H; Patócs A; Igaz P
    Orv Hetil; 2017 Apr; 158(13):483-490. PubMed ID: 28347154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating MicroRNAs: A Next-Generation Clinical Biomarker for Digestive System Cancers.
    Kawaguchi T; Komatsu S; Ichikawa D; Tsujiura M; Takeshita H; Hirajima S; Miyamae M; Okajima W; Ohashi T; Imamura T; Kiuchi J; Konishi H; Shiozaki A; Okamoto K; Otsuji E
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27598137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating microRNAs as potential new biomarkers for prostate cancer.
    Sita-Lumsden A; Dart DA; Waxman J; Bevan CL
    Br J Cancer; 2013 May; 108(10):1925-30. PubMed ID: 23632485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Small RNAs have a large impact: circulating microRNAs as biomarkers for human diseases.
    Weiland M; Gao XH; Zhou L; Mi QS
    RNA Biol; 2012 Jun; 9(6):850-9. PubMed ID: 22699556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating miRNA and cancer diagnosis.
    Tie Y; Liu B; Fu H; Zheng X
    Sci China C Life Sci; 2009 Dec; 52(12):1117-22. PubMed ID: 20016968
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Specific miRNA Disease Biomarkers in Blood, Serum and Plasma: Challenges and Prospects.
    Backes C; Meese E; Keller A
    Mol Diagn Ther; 2016 Dec; 20(6):509-518. PubMed ID: 27378479
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNAs in body fluids--the mix of hormones and biomarkers.
    Cortez MA; Bueso-Ramos C; Ferdin J; Lopez-Berestein G; Sood AK; Calin GA
    Nat Rev Clin Oncol; 2011 Jun; 8(8):467-77. PubMed ID: 21647195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating cell-free microRNAs as clinical cancer biomarkers.
    Armand-Labit V; Pradines A
    Biomol Concepts; 2017 May; 8(2):61-81. PubMed ID: 28448269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The validity of circulating microRNAs in oncology: five years of challenges and contradictions.
    Jarry J; Schadendorf D; Greenwood C; Spatz A; van Kempen LC
    Mol Oncol; 2014 Jun; 8(4):819-29. PubMed ID: 24656978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical relevance of circulating cell-free microRNAs in ovarian cancer.
    Nakamura K; Sawada K; Yoshimura A; Kinose Y; Nakatsuka E; Kimura T
    Mol Cancer; 2016 Jun; 15(1):48. PubMed ID: 27343009
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum microRNAs as powerful cancer biomarkers.
    Wittmann J; Jäck HM
    Biochim Biophys Acta; 2010 Dec; 1806(2):200-7. PubMed ID: 20637263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery and Evaluation of Extracellular MicroRNA Biomarkers in Plasma, Ascites, and Urine.
    Záveský L; Slanař O
    Methods Mol Biol; 2023; 2630():135-143. PubMed ID: 36689181
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extracellular microRNA: a new source of biomarkers.
    Etheridge A; Lee I; Hood L; Galas D; Wang K
    Mutat Res; 2011 Dec; 717(1-2):85-90. PubMed ID: 21402084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.